PT3369429T - Composição farmacêutica para administração na mucosa nasal - Google Patents

Composição farmacêutica para administração na mucosa nasal

Info

Publication number
PT3369429T
PT3369429T PT168600252T PT16860025T PT3369429T PT 3369429 T PT3369429 T PT 3369429T PT 168600252 T PT168600252 T PT 168600252T PT 16860025 T PT16860025 T PT 16860025T PT 3369429 T PT3369429 T PT 3369429T
Authority
PT
Portugal
Prior art keywords
administred
pharmaceutical composition
nasal mucosa
composition intended
intended
Prior art date
Application number
PT168600252T
Other languages
English (en)
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of PT3369429T publication Critical patent/PT3369429T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PT168600252T 2015-10-30 2016-10-28 Composição farmacêutica para administração na mucosa nasal PT3369429T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015214481 2015-10-30

Publications (1)

Publication Number Publication Date
PT3369429T true PT3369429T (pt) 2020-02-20

Family

ID=58630599

Family Applications (1)

Application Number Title Priority Date Filing Date
PT168600252T PT3369429T (pt) 2015-10-30 2016-10-28 Composição farmacêutica para administração na mucosa nasal

Country Status (17)

Country Link
US (1) US10849978B2 (pt)
EP (1) EP3369429B1 (pt)
JP (1) JP6629877B2 (pt)
KR (1) KR20180066071A (pt)
CN (1) CN108135959B (pt)
AU (1) AU2016346823A1 (pt)
BR (1) BR112018005811A2 (pt)
CA (1) CA2995839A1 (pt)
DK (1) DK3369429T3 (pt)
ES (1) ES2774128T3 (pt)
HK (1) HK1249856A1 (pt)
MX (1) MX2018005363A (pt)
PL (1) PL3369429T3 (pt)
PT (1) PT3369429T (pt)
RU (1) RU2725664C2 (pt)
TW (1) TWI745313B (pt)
WO (1) WO2017073798A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210052872A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Drug administration method
CA3112185A1 (en) * 2018-09-20 2020-03-26 Levo Therapeutics, Inc. Stable intranasal formulations of carbetocin
FR3088193B1 (fr) * 2018-11-13 2021-01-22 Andrea Fox Composition aqueuse, son procede de fabrication, et dispositif d’administration nasal

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5142420A (en) 1974-10-08 1976-04-10 Matsushita Electric Ind Co Ltd Tajushingobunrihoshiki
JPS60123426A (ja) 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
JP2734554B2 (ja) 1988-09-12 1998-03-30 藤沢薬品工業株式会社 インスリン様成長因子ｉの点鼻用液剤
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
JP3705620B2 (ja) 1994-12-28 2005-10-12 帝国臓器製薬株式会社 経粘膜投与用製剤
US5521283A (en) * 1995-01-31 1996-05-28 Eli Lilly And Company Anti-obesity proteins
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US8268791B2 (en) 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9023793B2 (en) * 2006-09-29 2015-05-05 Retrophin, Inc. Intranasal carbetocin formulations and methods for the treatment of autism
CA2689476C (en) * 2007-06-07 2014-08-05 Nastech Pharmaceutical Company Inc. Intranasal carbetocin formulations and methods for the treatment of autism
WO2011108521A1 (ja) * 2010-03-02 2011-09-09 国立大学法人徳島大学 粘膜ワクチン
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
JP6304744B2 (ja) * 2013-12-20 2018-04-04 国立大学法人福井大学 愛着障害治療剤

Also Published As

Publication number Publication date
TW201729830A (zh) 2017-09-01
DK3369429T3 (da) 2020-02-10
JP6629877B2 (ja) 2020-01-15
WO2017073798A1 (ja) 2017-05-04
US20180228902A1 (en) 2018-08-16
CN108135959A (zh) 2018-06-08
ES2774128T3 (es) 2020-07-16
HK1249856A1 (zh) 2018-11-16
RU2018118986A3 (pt) 2020-01-15
RU2725664C2 (ru) 2020-07-03
EP3369429A1 (en) 2018-09-05
MX2018005363A (es) 2018-09-05
CA2995839A1 (en) 2017-05-04
EP3369429A4 (en) 2018-10-31
AU2016346823A1 (en) 2018-03-08
JPWO2017073798A1 (ja) 2018-05-31
TWI745313B (zh) 2021-11-11
CN108135959B (zh) 2021-12-31
US10849978B2 (en) 2020-12-01
EP3369429B1 (en) 2019-12-11
BR112018005811A2 (pt) 2018-10-16
RU2018118986A (ru) 2019-12-02
PL3369429T3 (pl) 2020-06-15
KR20180066071A (ko) 2018-06-18

Similar Documents

Publication Publication Date Title
LT3030262T (lt) Kombinuota farmacinė kompozicija
IL246377A0 (en) Pharmaceutical preparations for oral administration
SG10201802104QA (en) Pharmaceutical composition of s-ketamine hydrochloride
SG11201507358VA (en) Pharmaceutical composition of s-ketamine hydrochloride
HK1244691A1 (zh) 用於施用於粘膜的藥物劑型
ZA201601656B (en) Inhalable pharmaceutical composition
HK1231390A1 (zh) 用於局部給藥的藥用組合物
PL2777689T3 (pl) Nowa kompozycja farmaceutyczna do leczenia zakażeń grzybiczych
SG11201601477VA (en) Pharmaceutical composition
HK1249856A1 (zh) 鼻粘膜給藥用藥物組合物
GB201320932D0 (en) Topical pharmaceutical composition
HUE047203T2 (hu) Gyógyászati kompozíció alkalmazásra orrnyálkahártya trofizmusának növekedésében
HK1220143A1 (zh) 藥物組合物
ZA201604100B (en) Gastro-retentive oral pharmaceutical compositions